HER2CLIMB-02: A randomized, double-blind, phase III study of tucatinib or placebo with T-DM1 for unresectable locally advanced or metastatic HER2+ breast cancer Meeting Abstract
| Authors: | Hurvitz, S. A.; Vahdat, L. T.; Harbeck, N.; Wolff, A. C.; Tolaney, S. M.; Loi, S.; Masuda, N.; O'Shaughnessy, J.; Dong, C.; Walker, L.; Rustia, E.; Borges, V. |
| Abstract Title: | HER2CLIMB-02: A randomized, double-blind, phase III study of tucatinib or placebo with T-DM1 for unresectable locally advanced or metastatic HER2+ breast cancer |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S390 |
| Language: | English |
| ACCESSION: | WOS:000573469100353 |
| DOI: | 10.1016/j.annonc.2020.08.455 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 353TiP -- Source: Wos |
